WOLFE PETER (Chief Financial Officer) received a stock award from ZYVERSA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/20/2022ACC: 0001493152-22-035985
Officer· Chief Financial Officer
Since Dec 2022
+3K
Net shares
Net buyer
$8.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3K
Price / share
$2.88
Trade value
$8.64K
% of position
7.2%
12/16/2022
41.59K→44.59K
Total
Net shares
+3K
Net value
$8.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2022 | A · Award | +3K | $2.88 | $8.64K | 7.2% | 41.59K | 44.59K |
| Total | +3K | $8.64K | ||||||
Derivative Transactions0
No derivative transactions reported